Last update 21 Nov 2024
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent(Changchun Institute of Biological Products)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Inactivated vaccine, Prophylactic vaccine, Multivalent vaccine |
Synonyms 适普利尔 |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (11 Mar 2020), |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent(Changchun Institute of Biological Products)随机、盲法、阳性对照评价四价流感病毒裂解疫苗在6-35月龄健康受试者中的免疫原性和安全性的Ⅱ期临床试验
[Translation] A randomized, blinded, positive-controlled phase II clinical trial to evaluate the immunogenicity and safety of a quadrivalent influenza virus split vaccine in healthy subjects aged 6-35 months
单中心、随机、盲法、阳性对照评价四价流感病毒裂解疫苗在6-35月龄健康受试者中安全性和耐受性的I期临床试验
[Translation] A single-center, randomized, blinded, positive-controlled phase I clinical trial to evaluate the safety and tolerability of a quadrivalent influenza virus split vaccine in healthy subjects aged 6-35 months
A Multi-centered, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Combined Immunization of 23-valent Pneumococcal Polysaccharide Vaccine (PPV23) and Quadrivalent Inactivated Influenza Vaccine (IIV4)
100 Clinical Results associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent(Changchun Institute of Biological Products)
Login to view more data
100 Translational Medicine associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent(Changchun Institute of Biological Products)
Login to view more data
100 Patents (Medical) associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent(Changchun Institute of Biological Products)
Login to view more data
100 Deals associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent(Changchun Institute of Biological Products)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Influenza, Human | CN | 11 Mar 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free